These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469 [TBL] [Abstract][Full Text] [Related]
11. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. Girgis RE; Mathai SC; Krishnan JA; Wigley FM; Hassoun PM J Heart Lung Transplant; 2005 Oct; 24(10):1626-31. PubMed ID: 16210140 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank). Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502 [TBL] [Abstract][Full Text] [Related]
16. Treatment of pulmonary arterial hypertension in connective tissue disease. Grünig E Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693 [TBL] [Abstract][Full Text] [Related]
17. Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension. Low A; George S; Howard L; Bell N; Millar A; Tulloh RMR J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29444773 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Lettieri CJ; Nathan SD; Barnett SD; Ahmad S; Shorr AF Chest; 2006 Mar; 129(3):746-52. PubMed ID: 16537877 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension. Rhee RL; Gabler NB; Sangani S; Praestgaard A; Merkel PA; Kawut SM Am J Respir Crit Care Med; 2015 Nov; 192(9):1111-7. PubMed ID: 26291092 [TBL] [Abstract][Full Text] [Related]
20. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Ross DJ; Hough G; Hama S; Aboulhosn J; Belperio JA; Saggar R; Van Lenten BJ; Ardehali A; Eghbali M; Reddy S; Fogelman AM; Navab M Pulm Circ; 2015 Dec; 5(4):640-8. PubMed ID: 26697171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]